EDAP TMS gains CE mark for device to treat prostate cancer

06/20/2013 | MedGadget.com

EDAP TMS has earned the CE mark in Europe for its Focal•One robotic High-Intensity Focused Ultrasound device, which is used to treat prostate cancer patients in a noninvasive manner. The device combines MRI with real-time ultrasound imaging to target tumors better during therapy, among other features.

View Full Article in:

MedGadget.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ